serw-MX  [xml]  

 DeCS Categories

E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.760 Epidemiologic Study Characteristics .
E05.318.760.250 Clinical Studies as Topic .
E05.318.760.250.500 Clinical Trials as Topic .
E05.318.760.250.500.200 Clinical Trials, Phase I as Topic .
H02 Health Occupations .
H02.403 Medicine .
H02.403.220 Community Medicine .
H02.403.355 Geriatrics .
H02.403.400 Integrative Medicine .
H02.533 Nutritional Sciences .
H02.533.252 Child Nutrition Sciences .
M01 Persons .
M01.526 Occupational Groups .
M01.526.485 Health Personnel .
M01.526.485.353 Epidemiologists .
N02 Health Care Facilities, Manpower, and Services .
N02.360 Health Personnel .
N02.360.345 Epidemiologists .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.775 Epidemiologic Study Characteristics .
N05.715.360.775.088 Clinical Studies as Topic .
N05.715.360.775.088.500 Clinical Trials as Topic .
N05.715.360.775.088.500.200 Clinical Trials, Phase I as Topic .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.450 Epidemiologic Study Characteristics .
N06.850.520.450.250 Clinical Studies as Topic .
N06.850.520.450.250.250 Clinical Trials as Topic .
N06.850.520.450.250.250.200 Clinical Trials, Phase I as Topic .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.047 Uses of Epidemiology .
SP5.001.047.153 Efficacy .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.654 Hazards .
SP8.473.654.377 Environment .
SP8.473.654.377.012 Adaptation .
VS2 Health Surveillance of Products .
VS2.002 Drug and Narcotic Control .
VS2.002.003 Drug Evaluation .
VS2.002.003.001 Drug Approval .
VS2. Clinical Trials as Topic .
VS2. Clinical Trials, Phase I as Topic .
VS4 Environmental Health Surveillance .
VS4.002 Surveillance of the Workers Health .
 Synonyms & Historicals
Surveillance of the Workers Health .
A continuous and systematic activity to detect, comprehend, research and analyze the determinants and constraints of health problems related to the work processes and environments in their technological, social, organizational and epidemiological aspects with the purpose of planning interventions to eliminate them or control them. .
Integrative Medicine .
Medicine, Integrative .
The discipline concerned with using the combination of conventional allopathic medicine and ALTERNATIVE MEDICINE to address the biological, psychological, social, and spiritual aspects of health and illness. .
Epidemiologists .
Epidemiologist .
Qualified medical professionals who study the causes, incidence, and characteristic behavior of disease outbreaks or other health-related conditions and determine the interrelationships of hosts, agents, and environment related to the distribution and control of diseases. .
Adaptation .
Degree of Adaptability .
Life Skills .
The process and the result of physical, biological and psychological changes of an organism or a population in order to adjust to given environmental conditions. (Material V - Gunn, S.W.A. Multilingual Dictionary of Disaster Medicine and International Relief, 1990) .
Community Medicine .
Medicine, Community .
A branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community. .
Efficacy .
The benefits and advantages of the services, treatments, drugs or preventive measures or control that apply to an individual or to the community. Ideally, the determination of efficacy is based on the results of a randomized controlled trial. .
Child Nutrition Sciences .
Adolescent Nutrition Sciences .
Adolescent Nutritional Sciences .
Child Nutritional Sciences .
Infant Nutrition Sciences .
Infant Nutritional Sciences .
Adolescent Nutrition Science .
Adolescent Nutritional Science .
Child Nutrition Science .
Child Nutritional Science .
Infant Nutrition Science .
Infant Nutritional Science .
Nutrition Science, Adolescent .
Nutrition Science, Child .
Nutrition Science, Infant .
Nutrition Sciences, Adolescent .
Nutrition Sciences, Child .
Nutrition Sciences, Infant .
Nutritional Science, Adolescent .
Nutritional Science, Child .
Nutritional Science, Infant .
Nutritional Sciences, Adolescent .
Nutritional Sciences, Child .
Nutritional Sciences, Infant .
Science, Adolescent Nutrition .
Science, Adolescent Nutritional .
Science, Child Nutrition .
Science, Child Nutritional .
Science, Infant Nutrition .
Science, Infant Nutritional .
Sciences, Adolescent Nutrition .
Sciences, Adolescent Nutritional .
Sciences, Child Nutrition .
Sciences, Child Nutritional .
Sciences, Infant Nutrition .
Sciences, Infant Nutritional .
The study of NUTRITION PROCESSES as well as the components of food, their actions, interaction, and balance in relation to health and disease of children, infants or adolescents. .
Environmental Health Surveillance .
Health Surveillance of Environments .
Monitoring of the environment or the workplace to avoid risks to the environment and to health professionals and the exposed population, originated from the production, transportation, storage and use of substances, products and equipments. .
Geriatrics .
Gerontology .
The branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility. .
Clinical Trials, Phase I as Topic .
Clinical Trials, Phase 1 .
Drug Evaluation, FDA Phase 1 .
Drug Evaluation, FDA Phase I as Topic .
Evaluation Studies, FDA Phase 1 .
Human Microdosing Trials .
Microdosing Trials, Human .
Phase 1 Clinical Trials .
Human Microdosing Trial .
Microdosing Trial, Human .
Trial, Human Microdosing .
Trials, Human Microdosing .
Clinical Trials, Phase I .
Drug Evaluation, FDA Phase I .
Evaluation Studies, FDA Phase I .
Phase I Clinical Trials .
Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. .